Featured Courses

Moving Beyond Laxitives in Opioid-Induced Constipation: New Targets, New Strategies, New Outcomes

up to 2.5 AMA PRA Category 1 Credit(s)TM
1.0 ACPE Contact Hours

In this CME series, learners will review treatment strategies and practice challenges associated with managing OIC through the use of patient vignettes and faculty-facilitated audio Q&As, learn current and evolving approaches for the pharmacologic and non-pharmacologic management of OIC, and explore a series of OIC treatment questions and practice considerations for healthcare providers who are interested to learn about OIC or who currently manage patients with OIC.

Advanced Curriculum for Cysic Fibrosis: Integrating Genome-Driven Data with Patient-Centered Treatment Strategies

1.5 AMA PRA Category 1 Credit(s)™

Owing to the high frequency and serious nature of cystic fibrosis, the development of targeted therapies for the management of this disease has been an active area of research. Pharmaceuticals have recently been designed which with certain genetic...

Focus on Bone Health: Treating Osteoporosis, Preventing Fractures

1.0 AMA PRA Category 1 Credit(s)™

Osteoporosis, a growing health problem, has serious long-term consequences of the fractures that result from the weakened bone. These include interference with activities of daily living, loss of independence, debilitating pain, poor quality of life, and, notably...

Prescription Monitoring Programs An Important Tool to Decrease Diversion and Abuse of Opioids

0.5 AMA PRA Category 1 Credit(s)™

Prescription Drug Monitoring Programs (PDMPs), or Prescription Monitoring Programs (PMPs), are electronic databases that track the dispensing of controlled substances, including opioids. PDMPs have been shown to not only decrease diversion and...

Utilizing GLP-1 Receptor Agonists and Insulins: High-efficiency Therapies in the Optimal Management of Patients with Type 2 Diabetes

up to 1.0 AMA PRA Category 1 Credit(s)TM
up to 2.0 CBRN Contact Hours

In this MediTalk, leading experts in type 2 diabetes mellitus (T2DM) management will review the long recognized patient-, system-, and clinician-related barriers to insulin initiation and intensification and will provide strategies that have been...

 

Beyond Diagnosis: The Essential Role of MRI in Clinical Management of Multiple Sclerosis

1.0 AMA PRA Category 1 Credit(s)™

MRI plays an essential role in every aspect of MS: in addition to excluding other neurologic disorders, MRI is commonly used to document dissemination of lesions both in space (DIS) and time (DIT) based on established criteria. Beyond diagnosis, MRI can provide prognostic information for disease and disability progression, and can aid in...

Recent Clinical Advancements in Multiple Sclerosis: An ACTRIMS-ECTRIMS Meeting Reporter

1.0 AMA PRA Category 1 Credit(s)™

The 2014 Joint ACTRIMS-ECTRIMS Meeting was hosted in Boston, Massachusetts and provided attendees with current information on the basic and clinical issues in multiple sclerosis research. Multiple sclerosis is a rapidly evolving field through its clinical trial...

Primary Care Perspectives: The Effective Use of Mealtime and Basal Insulin Regimens in Patients with Type 2 Diabetes

up to 1.0 AMA PRA Category 1 Credit(s)™

One of the many barriers that clinicians who manage patients with type 2 diabetes mellitus (T2DM) who may be appropriate for insulin therapy is to overcome the misguided fear that patients have regarding their potential risk for hypoglycemia....

A Scientific and Clinical Update on Current and Emergent Therapeutics within Multiple Sclerosis: A 2014 Joint ACTRIMS-ECTRIMS Meeting Reporter

1.0 AMA PRA Category 1 Credit(s)™

This Elsevier Medical Meeting Reporter presents and summarizes important multiple sclerosis presentations and abstracts from the Joint Meeting of the American and European Committees for Treatment and Research of Multiple Sclerosis (ACTRIMS...

Therapeutic Strategies for the Treatment of Ocular Surface Disorders

1.0 AMA PRA Category 1 Credit(s)™

Ocular surface disease (OSD) is a very common disorder, which affects millions of Americans. OSD affects the cornea, conjunctiva, eye lids, meibomian glands, or pre-ocular tear film. The dysfunction of these components can result in damage to the ocular surface, which necessitates rapid recognition and intervention to prevent...

The Evolution of Multigene Panel Testing for Hereditary Cancers

1.5 AMA PRA Category 1 Credit(s)™

A thorough family history evaluation remains a critical tool that helps identify those patients who are at risk for hereditary cancer. The American College of Obstetricians and Gynecologists (ACOG) recommends that all women receive a family history...

Effective Management of Psoriasis and Psoriatic Arthritis: Insights on Current and Emerging Therapies and Enhanced Professional Collaboration

up to 1.5 AMA PRA Category 1 Credit(s)TM
up to 3.0 CBRN Contact Hours

In the first interactive MediTalk digital roundtable discussion in the series, the expert faculty will review the safety, efficacy, and limitations of the currently available therapies for managing patients with psoriasis and/or psoriatic arthritis (PsA). They will discuss...

Primary Care Strategies for the Management of Common Urological Disorders in Men

up to 1.0 AMA PRA Category 1 Credit(s)TM
up to 2.0 CBRN Contact Hours

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), frequently referred to as LUTS/BPH, is a common urological disorder in men that negatively impacts their quality of life. Primary care management of LUTS/BPH begins...

Managing the Critically-Ill Patient with Hyponatremia

1.0 AMA PRA Category 1 Credit(s)™

Hyponatremia is the most common electrolyte imbalance in hospitalized patients that is often misdiagnosed or undiagnosed due to its nonspecific symptoms. Early diagnosis and adequate treatment are crucial to prevent increased morbidity and mortality...

 

Owing to the high frequency and serious nature of cystic fibrosis, the development of targeted therapies for the management of this disease has been an active area of research. Pharmaceuticals have recently been designed which specifically target patients with certain genetic cystic fibrosis indicators allowing for a greater number of treatment...
The availability of more therapeutic options in the management of patients with dyslipidemia has opened an opportunity to evaluate clinical trial data, and the responsiveness to therapeutic agents. Evidence gathered via literature reviews, analysis of clinical trials, and interviews with thought leaders concludes that gaps in knowledge and...
Despite the availability of a number of therapeutic options, management of type 2 diabetes (T2DM) and hyperglycemia remains suboptimal. Evidence shows that physicians are not adequately individualizing incretin-based therapies as there is lack of clear understanding of the similarities and differences between various incretin-based therapies....
This Elsevier Medical Meeting Reporter will present and summarize important presentations and abstracts from the 66th Annual Meeting of the American Academy of Neurologists (AAN). AAN is the world’s largest professional association of neurologists with over 26,000 members and strives to promote the highest caliber patient-centered neurologic...
Systemic lupus erythematosus (SLE) is a chronic, relapsing autoimmune disease of the connective tissues, primarily affecting the skin, kidneys, heart, lungs, nervous system, blood, and joints. SLE is characterized by cytokine dysregulation, polyclonal B-cell activation, autoantibody production, and increased immune complex formation due to...
Recent studies have changed the landscape and thinking on anticoagulation management and stroke prevention in patients with cardiac disease. Therapeutic options now include agents with unique modes of action and exciting new data on patient outcomes. This CME initiative will educate healthcare providers on the current applications of oral...
With the advent of JAK2 inhibitors, viable, clinically important treatment options are now becoming available and there is a clear need for focused educational efforts on the diagnosis and prognostic risk-based treatment approaches to myelofibrosis. This unique webcast will be led and developed by a panel of expert physicians who specialize in...
The management of patients with rheumatoid arthritis actively evolves as further evidence-based data becomes available. The relatively recent development of biologics and DMARDS has presented new challenges in clinical decision making for the busy rheumatologist. This program is designed to provide a review of immunology science which is necessary...
This Medical Meeting Reporter will present and summarize important presentations and abstracts from the 66th Annual Meeting of the American Academy of Neurologists (AAN). AAN is the world’s largest professional association of neurologists with over 26,000 members and strives to promote the highest caliber patient-centered neurologic care....
Given the rapidly evolving field of cardiac stress testing with respect to new risk stratification algorithms, new agents, and new assessment methods, it is difficult for physicians to remain up to date on the latest research and the benefits and risks of different testing modalities. This CME activity provides an overview on the indications and...

 

Controversies in the Treatment of Male Hypogonadism
1.00 AMA PRA Category 1 Credit(s)™

This CME program provides urologists and other healthcare providers an awareness of the various conflicting definitions of hypogonadism, screening guidelines, and the clinical data supporting the benefits and relative safety of testosterone replacement therapy.